Direct Effects of D-Chiro-Inositol on Insulin Signaling and Glucagon Secretion of Pancreatic Alpha Cells

Biomolecules. 2020 Oct 4;10(10):1404. doi: 10.3390/biom10101404.

Abstract

The insulin resistance state of pancreatic α-cells seems to be related to glucagon hypersecretion in type 2 diabetes. Treatment that can improve the insulin sensitivity of α-cells could control glucagon levels in patients with diabetes mellitus. The aim of this study was to investigate the preventive role of D-chiro-inositol (DCI), which has insulin receptor-sensitizer effects on insulin signaling pathways and glucagon secretion in pancreatic α-TC1 clone 6 cells. Cells were chronically treated with palmitate to induce insulin resistance in the presence/absence of DCI. DCI treatment improved the insulin signaling pathway and restored insulin-mediated glucagon suppression in α-TC1-6 cells exposed to palmitate. These results indicate that DCI treatment prevents the insulin resistance of α-TC1-6 cells chronically exposed to palmitate. Our data provide evidence that DCI could be useful to improve the insulin sensitivity of pancreatic α-cells in diabetes treatment.

Keywords: D-chiro-inositol; insulin resistance; lipotoxicity; α-cells.

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Glucagon / metabolism*
  • Glucagon-Secreting Cells / metabolism*
  • Inositol / pharmacology*
  • Insulin / pharmacology*
  • Insulin Resistance*
  • Mice
  • Palmitic Acid / pharmacology
  • Signal Transduction / drug effects*

Substances

  • Insulin
  • Palmitic Acid
  • Inositol
  • Glucagon